[{"Assets_0_Q3_USD":57433000000.0,"EarningsPerShareDiluted_3_Q3_USD":2.75,"EarningsPerShareDiluted_1_Q3_USD":0.83,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":1634000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1632000000.0,"EarningsPerShareBasic_3_Q3_USD":2.75,"EarningsPerShareBasic_1_Q3_USD":0.83,"StockholdersEquityConverted_0_Q3_USD":17754000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":1636000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":1634000000.0,"StockholdersEquity_0_Q3_USD":17648000000.0,"RevenuesConverted_3_Q3_USD":18200000000.0,"RevenuesConverted_1_Q3_USD":6007000000.0,"NetIncomeLossConverted_3_Q3_USD":4495000000.0,"NetIncomeLossConverted_1_Q3_USD":1353000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":6029000000.0,"CommonStockDividendsPerShareDeclared_1_Q3_USD":0.41,"CommonStockDividendsPerShareDeclared_3_Q3_USD":0.41,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20191031"}]